Push For Genetically Engineered Therapeutics Drives Cell-Culture Market

Cell-Culture Market Biotechnology and biopharmaceutical companies are putting the pressure on manufacturers of cell-culture equipment and supplies to create products that will enable researchers to culture cells more efficiently and in large amounts. The increased need for these products is an outgrowth of the growing demand for genetically engineered products with proven or potential therapeutic value. The laboratory products industry is responding with new types of cell-culture vessels that

| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

Cell-Culture Market Biotechnology and biopharmaceutical companies are putting the pressure on manufacturers of cell-culture equipment and supplies to create products that will enable researchers to culture cells more efficiently and in large amounts. The increased need for these products is an outgrowth of the growing demand for genetically engineered products with proven or potential therapeutic value.

The laboratory products industry is responding with new types of cell-culture vessels that boast specially treated surfaces to which cultured cells may firmly adhere. Also on the market are new formulations of culture media, as well as instruments that allow researchers to grow vast quantities of cells while continuously collecting the prized protein product that the cells secrete as they grow in culture.

Several types of cells, from sources as diverse as bacteria and humans, retain their ability to synthesize and secrete the protein products characteristic of the tissue from whence they came. In ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Holly Ahern

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo